These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29337848)

  • 1. Transmission Networks of HCV Genotype 1a Enriched With Pre-existing Polymorphism Q80K Among HIV-Infected Patients With Acute Hepatitis C in Poland.
    Parczewski M; Cielniak I; Kordek J; Aksak-Wąs B; Urbańska A; Leszczyszyn-Pynka M; Siwak E; Bociąga-Jasik M; Nowak A; Szymczak A; Zalewska M; Łojewski W; Vandamme AM; Lübke N; Cuypers L
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):514-522. PubMed ID: 29337848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus (HCV) genotype 1 NS5A resistance-associated variants are associated with advanced liver fibrosis independently of HCV-transmission clusters.
    Parczewski M; Kordek J; Janczewska E; Pisula A; Łojewski W; Socha Ł; Wawrzynowicz-Syczewska M; Bociąga-Jasik M; Szymczak A; Cielniak I; Siwak E; Mularska E; Aksak-Wąs B; Urbańska A; Lübke N
    Clin Microbiol Infect; 2019 Apr; 25(4):513.e1-513.e6. PubMed ID: 29981869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands.
    Newsum AM; Ho CK; Lieveld FI; van de Laar TJ; Koekkoek SM; Rebers SP; van der Meer JT; Wensing AM; Boland GJ; Arends JE; van Erpecum KJ; Prins M; Molenkamp R; Schinkel J
    AIDS; 2017 Jan; 31(1):105-112. PubMed ID: 27898592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.
    Nevot M; Boesecke C; Parera M; Andrés C; Franco S; Revollo B; Ingiliz P; Tural C; Clotet B; Rockstroh JK; Martinez MA;
    J Viral Hepat; 2014 Jun; 21(6):e19-28. PubMed ID: 24674023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region.
    Sarrazin C; Lathouwers E; Peeters M; Daems B; Buelens A; Witek J; Wyckmans Y; Fevery B; Verbinnen T; Ghys A; Schlag M; Baldini A; De Meyer S; Lenz O
    Antiviral Res; 2015 Apr; 116():10-6. PubMed ID: 25614456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of natural resistance to NS3 protease inhibitors in hepatitis C genotype 1a separated into clades 1 and 2 and in genotype 1b of HIV-infected patients.
    Bagaglio S; Uberti-Foppa C; Messina E; Merli M; Hasson H; Andolina A; Galli A; Lazzarin A; Morsica G
    Clin Microbiol Infect; 2016 Apr; 22(4):386.e1-386.e3. PubMed ID: 26706617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing.
    Margeridon-Thermet S; Le Pogam S; Li L; Liu TF; Shulman N; Shafer RW; Najera I
    PLoS One; 2014; 9(8):e105569. PubMed ID: 25140696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms associated with resistance to protease inhibitors in naïve patients infected with hepatitis C virus genotype 1 in Argentina: Low prevalence of Q80K.
    Martínez AP; Culasso ACA; Pérez PS; Romano V; Campos RH; Ridruejo E; García G; Di Lello FA
    Virus Res; 2017 Aug; 240():140-146. PubMed ID: 28837817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the NS3 Q80K polymorphism by Sanger and deep sequencing in hepatitis C virus genotype 1a strains in the UK.
    Beloukas A; King S; Childs K; Papadimitropoulos A; Hopkins M; Atkins M; Agarwal K; Nelson M; Geretti AM
    Clin Microbiol Infect; 2015 Nov; 21(11):1033-9. PubMed ID: 26232533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phylogenetic analysis of an epidemic outbreak of acute hepatitis C in HIV-infected patients by ultra-deep pyrosequencing.
    Caro-Pérez N; Martínez-Rebollar M; Gregori J; Quer J; González P; Gambato M; García-González N; González-Candelas F; Costa J; Esteban JI; Mallolas J; Forns X; Laguno M; Pérez-Del-Pulgar S
    J Clin Virol; 2017 Jul; 92():42-47. PubMed ID: 28521213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deconvoluting the composition of low-frequency hepatitis C viral quasispecies: comparison of genotypes and NS3 resistance-associated variants between HCV/HIV coinfected hemophiliacs and HCV monoinfected patients in Japan.
    Ogishi M; Yotsuyanagi H; Tsutsumi T; Gatanaga H; Ode H; Sugiura W; Moriya K; Oka S; Kimura S; Koike K
    PLoS One; 2015; 10(3):e0119145. PubMed ID: 25748426
    [TBL] [Abstract][Full Text] [Related]  

  • 12.  Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection.
    Lieveld FI; Swaans N; Newsum AM; Ho CK; Schinkel J; Molenkamp R; van der Meer JT; Arends JE; Hoepelman AI; Wensing AM; Siersema PD; van Erpecum KJ; Boland GJ
    Ann Hepatol; 2016; 15(5):696-704. PubMed ID: 27493108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Previous failure of interferon-based therapy does not alter the frequency of HCV NS3 protease or NS5B polymerase inhibitor resistance-associated variants: longitudinal analysis in HCV/HIV co-infected patients.
    Sede MM; Laufer NL; Quarleri J
    Int J Antimicrob Agents; 2015 Aug; 46(2):219-24. PubMed ID: 26100213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of hepatitis C virus Q80K among NS3 baseline-resistance-associated amino acid variants in direct-antiviral-agent-naïve patients with chronic hepatitis: single-centre experience.
    Ruggiero T; Proietti A; Boglione L; Milia MG; Allice T; Burdino E; Orofino G; Bonora S; Di Perri G; Ghisetti V
    Arch Virol; 2015 Nov; 160(11):2881-5. PubMed ID: 26249823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of resistance-associated variants to NS5A in HCV subtypes 1a and 1b in Taiwan.
    Tsai MC; Hung CH; Lu SN; Wang JH; Chen CH; Kee KM; Chang KC; Chao TL; Hu TH
    Biomed J; 2021 Dec; 44(6 Suppl 1):S126-S131. PubMed ID: 35123932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Screening for Naturally Occurring Hepatitis C Virus Resistance to Direct-Acting Antivirals in the NS3, NS5A, and NS5B Genes in Worldwide Isolates of Viral Genotypes 1 to 6.
    Patiño-Galindo JÁ; Salvatierra K; González-Candelas F; López-Labrador FX
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2402-16. PubMed ID: 26856832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategies.
    Grandal M; Pernas B; Tabernilla A; Mariño A; Álvarez H; Valcarce N; Mena A; Castro-Iglesias A; Pérez AB; Delgado M; Poveda E
    J Med Virol; 2018 Jun; 90(6):1094-1098. PubMed ID: 29427437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally Occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive HCV Genotype 6a-Infected Patients.
    Li Z; Liu Y; Zhang Y; Shao X; Luo Q; Guo X; Lin G; Cai Q; Zhao Z; Chong Y
    Biomed Res Int; 2017; 2017():9849823. PubMed ID: 29164151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naïve HIV/HCV Co-Infected Patients in China.
    Zhou K; Liang Z; Wang C; Hu F; Ning C; Lan Y; Tang X; Tucker JD; Cai W
    PLoS One; 2016; 11(6):e0157438. PubMed ID: 27341031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited overlap between phylogenetic HIV and hepatitis C virus clusters illustrates the dynamic sexual network structure of Dutch HIV-infected MSM.
    Vanhommerig JW; Bezemer D; Molenkamp R; Van Sighem AI; Smit C; Arends JE; Lauw FN; Brinkman K; Rijnders BJ; Newsum AM; Bruisten SM; Prins M; Van Der Meer JT; Van De Laar TJ; Schinkel J;
    AIDS; 2017 Sep; 31(15):2147-2158. PubMed ID: 28692530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.